Physician

Scott Brandon Mccord, M.D.

According to 2025 Medicare claims, Scott Mccord, M.D. (NPI: 1891131488) practices hematology/oncology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1033386578; TIN: 752131429) and primary practice location at 76177-1507. Mccord is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.

Mccord's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 480 traditional Medicare patients, billed 121,242 HCPCS/CPT codes, and received $2,004,895 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 865 prescription claims across 151 beneficiaries totaling $3,031,665 in drug costs, led by Revlimid (Lenalidomide). 2023 DME data shows 27 claims. Open Payments data shows 52 records totaling $2,065. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $216,202 to $2,004,895. Similarly, Part D prescription costs have risen steadily, from $6,406 to $3,031,665. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.